#099 The Science of Exercise for Cancer | Kerry Courneya, PhD

What It Covers

Dr. Kerry Courneya, Canada Research Chair at University of Alberta with over 600 peer-reviewed studies, explains how exercise functions as therapeutic intervention for cancer prevention, treatment, and survivorship. The discussion covers optimal exercise protocols for reducing cancer risk across eight to ten cancer types, mechanisms by which exercise improves chemotherapy tolerance and survival outcomes, and emerging research on exercise as monotherapy for low-grade cancers under active surveillance.

Key Questions Answered

• •Cancer Prevention Dose Response: Exercise reduces risk of eight to ten cancer types with clear dose-response relationship. Minimum 150 minutes weekly moderate intensity or 75 minutes vigorous intensity provides baseline protection, but benefits continue up to 300 minutes weekly before plateauing. Vigorous exercise receives double weighting in guidelines, meaning 75 minutes vigorous equals 150 minutes moderate. Exercise lowers cancer risk even in high-risk populations including obese individuals, smokers, and those with family history, working through mechanisms independent of weight loss.
• •Exercise During Chemotherapy Completion: Patients who exercise during chemotherapy complete more treatment cycles with fewer dose reductions and delays compared to sedentary patients. One study showed weight training group specifically completed more chemotherapy than aerobic or usual care groups, potentially due to gaining over one kilogram lean muscle during treatment which aids drug metabolism. Completing full chemotherapy doses on schedule directly correlates with lower recurrence risk and higher cure rates, making exercise adherence during treatment critical for survival outcomes.
• •Tumor Blood Flow and Drug Delivery: Exercise improves tumor vasculature quality and density, enhancing chemotherapy drug delivery and oxygen perfusion to tumors. Rectal cancer patients who exercised during chemoradiation therapy showed higher complete response rates with tumors eliminated before surgery compared to non-exercising patients. Better oxygenated tumors become more radiosensitive, as radiation therapy requires oxygen to be effective. This mechanism makes exercise a potential adjuvant therapy that enhances standard treatment effectiveness rather than just managing side effects.
• •Circulating Tumor Cell Shear Stress: Exercise increases hemodynamic shear stress in blood vessels, which kills circulating tumor cells attempting to metastasize from primary tumors. Preclinical microfluidic studies spinning tumor cells through tubes at varying speeds demonstrate faster flow rates consistent with exercise kill more cancer cells. Human studies show exercising patients have fewer circulating tumor cells, which directly correlates with lower metastasis rates. This pressure-washing effect may prevent cancer spread during the critical window when primary tumors shed cells into bloodstream.
• •Muscle Mass as Survival Predictor: Low muscle mass or muscle loss during cancer treatment predicts worse recurrence and mortality outcomes across cancer types. Cancer cachexia, the muscle wasting syndrome in advanced disease, proves extremely difficult to reverse once established. Resistance training two to three days weekly using eight exercises covering major muscle groups at moderate intensity prevents muscle loss during treatment. Building muscle reserve before diagnosis through regular strength training provides protective buffer against treatment-related muscle wasting and improves treatment tolerance.
• •High-Intensity Intervals for Active Surveillance: Men with low-grade prostate cancer on active surveillance who performed high-intensity interval training showed reduced PSA levels and their blood serum inhibited prostate cancer cell growth in laboratory tests. Active surveillance patients receive no standard treatments, creating opportunity for exercise as monotherapy. High-intensity exercise appears to activate stronger biological responses including anti-inflammatory effects, insulin and IGF reduction, and immune system stimulation compared to moderate intensity. This approach may delay or prevent need for aggressive treatments in early-stage cancers.
• •Psychological Benefits and Fear Reduction: Exercise reduces fear of cancer progression and recurrence, which can paralyze patients between surveillance appointments. Cancer patients report psychological benefits including restored sense of control and normalcy often outweigh physical benefits in importance to quality of life. Exercise demonstrates equivalent or superior effectiveness to SSRI medications for depression treatment while providing additional cardiovascular, metabolic, and immune benefits. The combination of biological effects on neurotransmitters plus psychological empowerment from taking active role creates synergistic mental health improvements during and after treatment.